Articles Tagged With:
-
A Closer Look at a New Low-Dose Copper IUD
This study reports on the three-year data from an ongoing Phase III study evaluating the efficacy, safety, and tolerability of a new low-dose copper intrauterine device (IUD), demonstrating low rates of expulsion and discontinuation and expanding the nonhormonal IUD options available in the United States.
-
Addressing Patient Opioid Use Disorder in Primary Care
Primary care providers (PCPs) play a critical role in diagnosing and treating opioid use disorder (OUD). By approaching OUD as a chronic disease, using non-stigmatizing language, and integrating team-based care, PCPs can provide accessible, effective treatment.
-
Abortion-Providing Clinicians Are Shifting Careers and Locations to Meet Needs
Clinicians in the study included nurses, advanced practice practitioners, and clinicians in family medicine.
-
Ensuring Sexual Health Education Addresses Patient Needs
Clinicians can help make sure patients have the information they need about sexual health and contraception.
-
Steps Clinicians Can Take to Improve Contraception Options for Patients
The important thing is to ensure patient autonomy in selecting a method that works best for them — even when contraception options are limited. Clinicians also can help patients obtain their desired method of birth control.
-
Physicians Could Prescribe Period Pills to Patients Who Are Late But Not Tested
Period pills could become a more popular contraceptive option in the future as clinicians and women explore new ways to maintain reproductive autonomy.
-
The Cancer-Prevention Benefits of Opportunistic Bilateral Salpingectomies
As increasing numbers of patients seek permanent contraception in the United States, it is clinically important for OB/GYNs to talk with them about an important health benefit of bilateral salpingectomy, which is a safe procedure for both permanent contraception and to prevent ovarian cancer, research shows.
-
Sebetralstat Tablets (Ekterly)
The U.S. Food and Drug Administration has approved sebetralstat, the first oral, on-demand treatment for acute attacks of hereditary angioedema. Sebetralstat is a selective competitive, reversible plasma kallikrein inhibitor. It is distributed by KalVista Pharmaceuticals Inc as Ekterly.
-
Contemporary Cardiovascular Disease Deaths in Asian Americans
An analysis of a Centers for Disease Control and Prevention database has shown the cardiovascular disease mortality rate is higher in Asian Americans than in non-Asian Americans and that this excess mortality is particularly prevalent in Filipino Americans.
-
Fidaxomicin Is More Clinically Effective than Vancomycin for C. difficile Infection
There is a lack of real-world data on using fidaxomicin for Clostridioides difficile infection (CDI). A retrospective, single-center study found that treatment of CDI with fidaxomicin leads to reduced clinical failure compared to oral vancomycin.